Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Colorectal cancer screening in newly insured Medicaid members: a review of concurrent federal and state policies.

O'Leary MC, Lich KH, Gu Y, Wheeler SB, Coronado GD, Bartelmann SE, Lind BK, Mayorga ME, Davis MM.

BMC Health Serv Res. 2019 May 9;19(1):298. doi: 10.1186/s12913-019-4113-2.

2.

Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program: Findings from the PROMPT Study.

Coronado GD, Thompson JH, Petrik AF, Nyongesa DB, Leo MC, Castillo M, Younger B, Escaron A, Chen A.

J Am Board Fam Med. 2019 May-Jun;32(3):318-328. doi: 10.3122/jabfm.2019.03.180275.

3.

Developing Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program in a Latino-Based Community Health Center.

Thompson JH, Davis MM, Michaels L, Rivelli JS, Castillo ML, Younger BM, Castro M, Reich SL, Coronado GD.

J Am Board Fam Med. 2019 May-Jun;32(3):307-317. doi: 10.3122/jabfm.2019.03.180026.

4.

A cost-effectiveness analysis of a colorectal cancer screening program in safety net clinics.

Meenan RT, Coronado GD, Petrik A, Green BB.

Prev Med. 2019 Mar;120:119-125. doi: 10.1016/j.ypmed.2019.01.014. Epub 2019 Jan 24.

PMID:
30685318
5.

Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.

Nielson CM, Vollmer WM, Petrik AF, Keast EM, Green BB, Coronado GD.

J Gen Intern Med. 2019 Jan 25. doi: 10.1007/s11606-018-4820-0. [Epub ahead of print]

PMID:
30684199
6.

Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing?

Davis MM, Shafer P, Renfro S, Hassmiller Lich K, Shannon J, Coronado GD, McConnell KJ, Wheeler SB.

BMC Health Serv Res. 2019 Jan 21;19(1):54. doi: 10.1186/s12913-018-3864-5.

7.

Pragmatic clinical trials offer unique opportunities for disseminating, implementing, and sustaining evidence-based practices into clinical care: Proceedings of a workshop.

Tuzzio L, Larson EB, Chambers DA, Coronado GD, Curtis LH, Weber WJ, Zatzick DF, Meyers CM.

Healthc (Amst). 2019 Mar;7(1):51-57. doi: 10.1016/j.hjdsi.2018.12.003. Epub 2018 Dec 26. Review.

8.

Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates.

Coury JK, Schneider JL, Green BB, Baldwin LM, Petrik AF, Rivelli JS, Schwartz MR, Coronado GD.

Transl Behav Med. 2018 Nov 16. doi: 10.1093/tbm/iby094. [Epub ahead of print]

PMID:
30445511
9.

Effectiveness of automated and live phone reminders after mailed-FIT outreach in a pilot randomized trial.

Nielson CM, Rivelli JS, Fuoco MJ, Gawlik VR, Jimenez R, Petrik AF, Coronado GD.

Prev Med Rep. 2018 Oct 17;12:210-213. doi: 10.1016/j.pmedr.2018.10.012. eCollection 2018 Dec.

10.

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial.

Nielson CM, Petrik AF, Jacob L, Vollmer WM, Keast EM, Schneider JL, Rivelli JS, Kapka TJ, Meenan RT, Mummadi RR, Green BB, Coronado GD.

Cancer Med. 2018 Sep;7(9):4781-4790. doi: 10.1002/cam4.1727. Epub 2018 Aug 13.

11.

Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.

Coronado GD, Petrik AF, Vollmer WM, Taplin SH, Keast EM, Fields S, Green BB.

JAMA Intern Med. 2018 Sep 1;178(9):1174-1181. doi: 10.1001/jamainternmed.2018.3629.

PMID:
30083752
12.

Mapping Multi-Site Clinic Workflows to Design Systems-Enabled Interventions.

Coronado GD, Retecki S, Petrik AF, Coury J, Aguirre J, Taplin SH, Burdick T, Green BB.

EGEMS (Wash DC). 2017 Jun 14;5(1):13. doi: 10.5334/egems.219.

13.

Application of improved approach to evaluate a community intervention to reduce exposure of young children living in farmworker households to organophosphate pesticides.

Griffith WC, Vigoren EM, Smith MN, Workman T, Thompson B, Coronado GD, Faustman EM.

J Expo Sci Environ Epidemiol. 2019 Apr;29(3):358-365. doi: 10.1038/s41370-018-0028-y. Epub 2018 Apr 17.

14.

Participatory Research to Advance Colon Cancer Prevention (PROMPT): Study protocol for a pragmatic trial.

Thompson JH, Davis MM, Leo MC, Schneider JL, Smith DH, Petrik AF, Castillo M, Younger B, Coronado GD.

Contemp Clin Trials. 2018 Apr;67:11-15. doi: 10.1016/j.cct.2018.02.001. Epub 2018 Feb 9.

15.

A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - How, what and when?

Davis MM, Freeman M, Shannon J, Coronado GD, Stange KC, Guise JM, Wheeler SB, Buckley DI.

BMC Cancer. 2018 Jan 6;18(1):40. doi: 10.1186/s12885-017-3813-4. Review.

16.

Mobile Versus Fixed Facility: Latinas' Attitudes and Preferences for Obtaining a Mammogram.

Scheel JR, Tillack AA, Mercer L, Coronado GD, Beresford SAA, Molina Y, Thompson B.

J Am Coll Radiol. 2018 Jan;15(1 Pt A):19-28. doi: 10.1016/j.jacr.2017.08.030. Epub 2017 Oct 19.

17.

Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches.

Coronado GD, Rivelli JS, Fuoco MJ, Vollmer WM, Petrik AF, Keast E, Barker S, Topalanchik E, Jimenez R.

J Gen Intern Med. 2018 Jan;33(1):72-78. doi: 10.1007/s11606-017-4184-x. Epub 2017 Oct 10.

18.

Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory.

Weinfurt KP, Hernandez AF, Coronado GD, DeBar LL, Dember LM, Green BB, Heagerty PJ, Huang SS, James KT, Jarvik JG, Larson EB, Mor V, Platt R, Rosenthal GE, Septimus EJ, Simon GE, Staman KL, Sugarman J, Vazquez M, Zatzick D, Curtis LH.

BMC Med Res Methodol. 2017 Sep 18;17(1):144. doi: 10.1186/s12874-017-0420-7.

19.

Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics.

Coury J, Schneider JL, Rivelli JS, Petrik AF, Seibel E, D'Agostini B, Taplin SH, Green BB, Coronado GD.

BMC Health Serv Res. 2017 Jun 19;17(1):411. doi: 10.1186/s12913-017-2364-3.

20.

Geographic and population-level disparities in colorectal cancer testing: A multilevel analysis of Medicaid and commercial claims data.

Davis MM, Renfro S, Pham R, Hassmiller Lich K, Shannon J, Coronado GD, Wheeler SB.

Prev Med. 2017 Aug;101:44-52. doi: 10.1016/j.ypmed.2017.05.001. Epub 2017 May 13.

21.

Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders.

Coronado GD, Schneider JL, Petrik A, Rivelli J, Taplin S, Green BB.

Transl Behav Med. 2017 Sep;7(3):557-566. doi: 10.1007/s13142-016-0461-1.

22.

Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems.

Larson EB, Tachibana C, Thompson E, Coronado GD, DeBar L, Dember LM, Honda S, Huang SS, Jarvik JG, Nelson C, Septimus E, Simon G, Johnson KE.

Healthc (Amst). 2016 Sep;4(3):138-41. doi: 10.1016/j.hjdsi.2015.07.005. Epub 2015 Jul 29.

23.

Seasonal and occupational trends of five organophosphate pesticides in house dust.

Smith MN, Workman T, McDonald KM, Vredevoogd MA, Vigoren EM, Griffith WC, Thompson B, Coronado GD, Barr D, Faustman EM.

J Expo Sci Environ Epidemiol. 2017 Jul;27(4):372-378. doi: 10.1038/jes.2016.45. Epub 2016 Aug 24.

PMID:
27553992
24.

The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics.

Petrik AF, Green BB, Vollmer WM, Le T, Bachman B, Keast E, Rivelli J, Coronado GD.

Fam Pract. 2016 Dec;33(6):639-643. Epub 2016 Jul 28.

25.

Multilevel Intervention Raises Latina Participation in Mammography Screening: Findings from ¡Fortaleza Latina!

Coronado GD, Beresford SA, McLerran D, Jimenez R, Patrick DL, Ornelas I, Bishop S, Scheel JR, Thompson B.

Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):584-92. doi: 10.1158/1055-9965.EPI-15-1246.

26.

Neighborhood Predictors of Mammography Barriers Among US-Based Latinas.

Molina Y, Plascak JJ, Patrick DL, Bishop S, Coronado GD, Beresford SA.

J Racial Ethn Health Disparities. 2017 Apr;4(2):233-242. doi: 10.1007/s40615-016-0222-3. Epub 2016 Apr 8.

27.

Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice.

Oluloro A, Petrik AF, Turner A, Kapka T, Rivelli J, Carney PA, Saha S, Coronado GD.

J Community Health. 2016 Aug;41(4):864-70. doi: 10.1007/s10900-016-0165-y.

28.

Analytic Challenges Arising from the STOP CRC Trial: Pragmatic Solutions for Pragmatic Problems.

Vollmer WM, Green BB, Coronado GD.

EGEMS (Wash DC). 2015 Dec 9;3(1):1200. doi: 10.13063/2327-9214.1200. eCollection 2015.

29.

Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.

Johnson KE, Neta G, Dember LM, Coronado GD, Suls J, Chambers DA, Rundell S, Smith DH, Liu B, Taplin S, Stoney CM, Farrell MM, Glasgow RE.

Trials. 2016 Jan 16;17:32. doi: 10.1186/s13063-016-1158-y.

30.

Engaging Study Participants in Research Dissemination at a Center for Population Health and Health Disparities.

Knerr S, Hohl SD, Molina Y, Neuhouser ML, Li CI, Coronado GD, Fullerton SM, Thompson B.

Prog Community Health Partnersh. 2016;10(4):569-576. doi: 10.1353/cpr.2016.0065.

31.

Recruiting community health centers into pragmatic research: Findings from STOP CRC.

Coronado GD, Retecki S, Schneider J, Taplin SH, Burdick T, Green BB.

Clin Trials. 2016 Apr;13(2):214-22. doi: 10.1177/1740774515608122. Epub 2015 Sep 29.

32.

Family/friend recommendations and mammography intentions: the roles of perceived mammography norms and support.

Molina Y, Ornelas IJ, Doty SL, Bishop S, Beresford SA, Coronado GD.

Health Educ Res. 2015 Oct;30(5):797-809. doi: 10.1093/her/cyv040. Epub 2015 Aug 31.

33.

Reasons for non-response to a direct-mailed FIT kit program: lessons learned from a pragmatic colorectal-cancer screening study in a federally sponsored health center.

Coronado GD, Schneider JL, Sanchez JJ, Petrik AF, Green B.

Transl Behav Med. 2015 Mar;5(1):60-7. doi: 10.1007/s13142-014-0276-x.

34.

Health Policy to Promote Colorectal Cancer Screening: Improving Access and Aligning Federal and State Incentives.

Coronado GD, Petrik AF, Bartelmann SE, Coyner LA, Coury J.

Clin Res (Alex). 2015 Feb;29(1):50-55. Epub 2015 Feb 1.

35.

A guide to research partnerships for pragmatic clinical trials.

Johnson KE, Tachibana C, Coronado GD, Dember LM, Glasgow RE, Huang SS, Martin PJ, Richards J, Rosenthal G, Septimus E, Simon GE, Solberg L, Suls J, Thompson E, Larson EB.

BMJ. 2014 Dec 1;349:g6826. doi: 10.1136/bmj.g6826. No abstract available.

36.

Using an Automated Data-driven, EHR-Embedded Program for Mailing FIT kits: Lessons from the STOP CRC Pilot Study.

Coronado GD, Burdick T, Petrik A, Kapka T, Retecki S, Green B.

J Gen Pract (Los Angel). 2014 Jan 5;2. pii: 1000141.

37.

Clinical perspectives on colorectal cancer screening at Latino-serving federally qualified health centers.

Coronado GD, Petrik AF, Spofford M, Talbot J, Do HH, Taylor VM.

Health Educ Behav. 2015 Feb;42(1):26-31. doi: 10.1177/1090198114537061. Epub 2014 Jun 20.

38.

Multi-level Intervention to increase participation in mammography screening: ¡Fortaleza Latina! study design.

Coronado GD, Jimenez R, Martinez-Gutierrez J, McLerran D, Ornelas I, Patrick D, Gutierrez R, Bishop S, Beresford SA.

Contemp Clin Trials. 2014 Jul;38(2):350-4. doi: 10.1016/j.cct.2014.06.008. Epub 2014 Jun 18.

PMID:
24952281
39.

Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.

Coronado GD, Vollmer WM, Petrik A, Taplin SH, Burdick TE, Meenan RT, Green BB.

Contemp Clin Trials. 2014 Jul;38(2):344-9. doi: 10.1016/j.cct.2014.06.006. Epub 2014 Jun 14.

40.

"BeneFITs" to increase colorectal cancer screening in priority populations.

Green BB, Coronado GD.

JAMA Intern Med. 2014 Aug;174(8):1242-3. doi: 10.1001/jamainternmed.2014.730. No abstract available.

41.

Navigating the murky waters of colorectal cancer screening and health reform.

Green BB, Coronado GD, Devoe JE, Allison J.

Am J Public Health. 2014 Jun;104(6):982-6. doi: 10.2105/AJPH.2014.301877. Epub 2014 Apr 17.

42.

A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States.

Escoffery C, Rodgers KC, Kegler MC, Haardörfer R, Howard DH, Liang S, Pinsker E, Roland KB, Allen JD, Ory MG, Bastani R, Fernandez ME, Risendal BC, Byrd TL, Coronado GD.

BMC Public Health. 2014 Mar 24;14:274. doi: 10.1186/1471-2458-14-274. Review.

43.

Variability in the take-home pathway: farmworkers and non-farmworkers and their children.

Thompson B, Griffith WC, Barr DB, Coronado GD, Vigoren EM, Faustman EM.

J Expo Sci Environ Epidemiol. 2014 Sep-Oct;24(5):522-31. doi: 10.1038/jes.2014.12. Epub 2014 Mar 5.

44.

Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes.

Coronado GD, Vollmer WM, Petrik A, Aguirre J, Kapka T, Devoe J, Puro J, Miers T, Lembach J, Turner A, Sanchez J, Retecki S, Nelson C, Green B.

BMC Cancer. 2014 Feb 26;14:55. doi: 10.1186/1471-2407-14-55.

45.

Understanding HPV vaccination among Latino adolescent girls in three U.S. regions.

Glenn BA, Tsui J, Coronado GD, Fernandez ME, Savas LS, Taylor VM, Bastani R.

J Immigr Minor Health. 2015 Feb;17(1):96-103. doi: 10.1007/s10903-014-9996-8.

PMID:
24557745
46.

Patient and clinical perspectives on changes to mammography screening guidelines.

Coronado GD, Gutierrez JM, Jhingan E, Angulo A, Jimenez R.

Breast J. 2014 Jan-Feb;20(1):105-6. doi: 10.1111/tbj.12219. Epub 2013 Nov 22. No abstract available.

47.

Advantages of wordless instructions on how to complete a fecal immunochemical test: lessons from patient advisory council members of a federally qualified health center.

Coronado GD, Sanchez J, Petrik A, Kapka T, DeVoe J, Green B.

J Cancer Educ. 2014 Mar;29(1):86-90. doi: 10.1007/s13187-013-0551-4.

48.

Perceptions of under and overutilization of cervical cancer screening services at Latino-serving community health centers.

Coronado GD, Petrik A, Spofford M, Talbot J, Do HH, Sanchez J, Kapka T, Taylor V.

J Community Health. 2013 Oct;38(5):915-8. doi: 10.1007/s10900-013-9701-1.

PMID:
23728821
49.

Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.

Livaudais JC, Lacroix A, Chlebowski RT, Li CI, Habel LA, Simon MS, Thompson B, Erwin DO, Hubbell FA, Coronado GD.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):365-73. doi: 10.1158/1055-9965.EPI-12-1225. Epub 2012 Dec 28.

50.

Issues in biomedical research: what do Hispanics think?

Ulrich A, Thompson B, Livaudais JC, Espinoza N, Cordova A, Coronado GD.

Am J Health Behav. 2013 Jan;37(1):80-5. doi: 10.5993/AJHB.37.1.9.

Supplemental Content

Loading ...
Support Center